Next Article in Journal
Quorum Sensing Inhibitory and Antifouling Activities of New Bromotyrosine Metabolites from the Polynesian Sponge Pseudoceratina n. sp.
Previous Article in Journal
Bactericidal Activity of Usnic Acid-Chitosan Nanoparticles against Persister Cells of Biofilm-Forming Pathogenic Bacteria
Previous Article in Special Issue
LC–HRMS and Chemical Derivatization Strategies for the Structure Elucidation of Caribbean Ciguatoxins: Identification of C-CTX-3 and -4
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

1H NMR-Based Isolation of Anti-Inflammatory 9,11-Secosteroids from the Octocoral Sinularia leptoclados

1
Research Center for Chinese Herbal Medicine, Graduate Institute of Healthy Industry Technology, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 333324, Taiwan
2
Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University, Taoyuan 333323, Taiwan
3
Department of Cosmetic Science, Providence University, Taichung 433303, Taiwan
4
Department of Nursing, Division of Basic Medical Sciences, Chang Gung University of Science and Technology, Taoyuan 333324, Taiwan
5
Department of Neurology, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan
6
National Museum of Marine Biology and Aquarium, Pingtung 944401, Taiwan
7
Graduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944401, Taiwan
8
Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung 404394, Taiwan
9
Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan
10
Department of Anaesthesiology, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan
11
Department of Chemical Engineering, Ming Chi University of Technology, New Taipei City 243303, Taiwan
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2020, 18(5), 271; https://doi.org/10.3390/md18050271
Submission received: 2 May 2020 / Revised: 18 May 2020 / Accepted: 19 May 2020 / Published: 21 May 2020

Abstract

:
Octocoral Sinularia leptoclados has been identified as a source of bioactive 9,11-secosteroids. This study adopted a targeted isolation approach to the discovery and analysis of five 9,11-secosteroids, including two novel compounds named sinleptosterols A (1) and B (2) as well as five known analogues (8αH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (3), 8βH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (4), leptosterol A (5), (24S)-3β,11-dihydroxy-24-methyl-9,11-secocholest-5-en-9-one (6), and 3β,11-dihydroxy-9,11-secogorgost-5-en-9-one (7)) in terms of 1H-NMR patterns and potency against neutrophilic inflammation. The structure of secosteroids 1 and 2 was deduced from general spectroscopic analysis and an examination of NMR spectra. Among the above-mentioned isolates, compound 4 had the most pronounced effect in inhibiting elastase release and superoxide anion generation, with the IC50 values of 2.96 and 1.63 μM, respectively.

1. Introduction

Inflammation is one aspect of the regular host reaction to injury or infection caused by toxic chemicals, dead cells, pathogens, irritants, or allergens. The important role of neutrophils in a variety of infectious and inflammatory diseases makes them an attractive target for therapeutic interventions [1]. Numerous herbs and plant-derived compounds have been found to alleviate inflammation [2]; however, very few sources have been identified in marine environments.
Soft corals are reported to produce a variety of secondary metabolites with diverse pharmacological activities. Most of the metabolites from soft corals are sesquiterpenes, diterpenes, and steroids [3]. The octocoral Sinularia leptoclados belongs to the order Alcyonacea, which has been shown to produce a remarkable diversity of steroids in large quantities [4,5,6]. The 9,11-secosteroids found in marine invertebrates such as sponges, corals, ascidian, and mollusk can be structurally characterized by the C-9/11 oxidative cleavage of the C-ring [7,8]. The potent inhibitory effects of 9,11-secosteroids toward neutrophilic inflammation [9,10,11] motivated the current study of chemical compositions with this structural feature.
In this study, an ethyl acetate (EtOAc) extract of S. leptoclados displayed notable anti-inflammatory activity (superoxide anion generation: IC50 3.97 μg/mL) following the isolated targeting of 9,11-secosteroids based on 1H-NMR and bioassay information. Column chromatography revealed two novel 9,11-secosteroids (sinleptosterols A (1) and B (2)) in addition to five known metabolites 37 (Figure 1). Most of the 9,11-secosterols isolated in this study displayed notable inhibitory effects on N-formyl-methionyl-leucyl-phenylalanine/cytochalasin B (fMLP/CB)-induced superoxide anion generation and elastase release.

2. Results and Discussion

2.1. 1H NMR-Based Isolation of Anti-Inflammatory 9,11-Secosteroids

Primary silica gel chromatographic fractionation was used to probe anti-inflammatory 9,11-secosteroids within the organic extract from S. leptoclados. Comprehensive chemical and biological profiles of all fractions (fractions A–V) were then constructed through 1H-NMR analysis and an examination of anti-inflammatory activity (Figure 2). Fraction P was selected for subsequent analysis due to its characteristic 9,11-secosteroidal 1H-NMR patterns (δH 3.51, 1H, m, H-3; 3.03, 1H, ddd, J = 12.4, 12.8, 6.8, H-8; 3.86, 1H, m; 3.74, 1H, m, H2-11) and potent anti-inflammatory activities (superoxide anion generation: IC50 3.57 μg/mL; elastase release: IC50 6.80 μg/mL). Consecutive column chromatographic processes (reverse phase) resulted in the isolation of two novel 9,11-secosteroids, (sinleptosterols A (1) and B (2)) as well as 8αH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (3) [12], 8βH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (4) [12], leptosterol A (5) [5], (24S)-3β,11-dihydroxy-24-methyl-9,11-secocholest-5-en-9-one (6) [5], and 3β,11-dihydroxy-9,11- secogorgost-5-en-9-one (7) [12] (Figure 1).

2.2. Chemical Identification of 9,11-Secosterols

Compound 1 was obtained as a colorless oil. Positive mode high resolution electrospray ionization mass spectrum ((+)-HRESIMS)) of 1 revealed a sodiated adduct ion peak at m/z 451.31811, which established the molecular formula C28H44O3 (calcd. for C28H44O3 + Na, 451.31827), indicating seven degrees of unsaturation. IR absorption observed at 3369, 2958, and 1708 cm−1 suggested the presence of hydroxy, alkene, and ketonic groups (see Supplementary Materials Figure S2). The 13C and distortionless enhancement by polarization transfer (DEPT) spectroscopic data revealed 28 carbon signals in this compound, (Table 1), including five methyls, eight sp3 methylenes (including an oxymethylene), one sp2 methylene, six sp3 methines (including one oxymethine), two sp3 quaternary carbons, three sp2 methines, and three sp2 quaternary carbons (including two olefin carbons and one ketonic carbonyl) (see Supplementary Materials Figure S5). It was found that the quaternary carbon signal at δC 217.5 (C-9) and the proton shifts at δH 1.40 (s, H3-19), 3.03 (ddd, J = 12.4, 12.4, 6.8 Hz, H-8), 3.51 (m, H-3), and 5.47 (d, J = 5.6 Hz, H-6) were similar to those of 3-hydroxy-9,11-seco-9- oxosterols (with a 5,6-double bond). A disubstituted alkene was recognized within the carbon signals at δC 134.6 (CH-22) and 130.2 (CH-23), and was further confirmed by two olefin proton signals at δH 5.65 (1H, dd, J = 16.0, 7.2 Hz, H-22) and 5.93 (1H, d, J = 16.0 Hz, H-23) (Table 1). Three methyl doublets at δH 1.08 (3H, J = 6.4 Hz), 1.06 (3H, J = 6.8 Hz), and 1.07 (3H, J = 6.8 Hz) can respectively be attributed to the Me-21, Me-26, and Me-27 methyl groups. Two sharp methyl singlets for H3-18 and H3-19 respectively appeared at δH 0.69 (3H, s) and 1.40 (3H, s). Taken together, these findings identify compound 1 as a tricyclic compound.
1H NMR coupling information within the correlation spectroscopy (COSY) data of 1 enabled identification of separate spin systems for H2-1/H2-2/H-3/H2-4, H2-11/H2-12, H-6/H2-7/H-8/H-14/H2-15/H2-16/H-17/H-20/H-22/H-23, H-20/H3-21, and H-25/H3-26/H3-27 (Table 1), which were experimentally assembled with the assistance of a heteronuclear multiple bond correlation (HMBC). Key HMBC between protons and quaternary carbons of 1, such as H-4, H2-7, H3-19/C-5; H-8, H-14, H3-19/C-9; H-6, H3-19/C-10; H2-12, H3-18/C-13 and H-22, H-23, H-25, H3-26, H3-27, H2-28/C-24, permitted elucidation of the carbon skeleton of 1 (Table 1).
The relative stereochemistry of 1 was explained in terms of correlations observed in a nuclear Overhauser effect spectroscopy (NOESY) experiment, and through a comparison of NMR data between 1 and known secosterol 5. The results suggest that these two compounds possess the same 9,11-secosterol skeleton as well as the same core A-, B-, and D-rings [5]. The configurations at C-3, C-8, C-10, C-13, C-14, and C-17 in 1 were found to be identical to those of 5. Key NOESY correlations for 1 displayed interactions between H-8/H3-18 and H-8/H3-19. Thus, H-8 should be located on the β-face (Figure 3). A large coupling constant (J = 16.0 Hz) indicated a trans relationship between H-22 and H-23. All these data allowed to identify compound (1) as depicted in Figure 1 and it was named sinleptosterol A.
The molecular formula of compound (2) was the same as that of 1 (C28H44O3), as determined by (+)-HRESIMS at m/z 451.3239 (calcd. for C28H44O3 + Na, 451.3188), with seven degrees of unsaturation. Its IR bands revealed the presence of hydroxy (3406 cm−1) and ketone (1708 cm−1) groups (see Supplementary Materials Figure S11). On the basis of the above analysis and a comparison of one-dimensional and two-dimensional NMR experiments on 2 (Table 2), the core structural systems of secosterol 2 were established. It was found that the 1H and 13C NMR chemical shifts of 2 (including coupling patterns and coupling constants) resembled those of 1; however, the signals corresponding to the disubstituted alkene between C-22/23 in 1 were replaced by aliphatic methylenes in 2, and one of the methyl groups at C-25 in 1 (Me-26) was replaced by an exocyclic carbon-carbon bond in 2.
The observed HMBC correlations fully supported the locations of the functional groups. An olefinic bond was located at C-25/26 from H2-26, H3-27, H3-28 to C-25, respectively; therefore, sinleptosterol B (2) was designated as structure 2. The relative configurations at C-3, C-8, C-10, C-13, C-14, and C-17 of 2 were found to be the same as those of 1 in the core rings A–C. Note that the stereogenic carbons were identical to those of 1, which were in agreement with the observed 1H and 13C NMR chemical shifts and proton coupling constants. Therefore, compound (2) was unambiguously identified as presented in Figure 1 and it was named sinleptosterol B.
Through a comparison of NMR spectroscopic data with those reported in the literature [5,12], the known compounds were identified as 8αH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (3), 8βH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (4), leptosterol A (5), (24S)-3β,11-dihydroxy-24-methyl-9,11-secocholest-5-en-9-one (6), and 3β,11-dihydroxy-9,11- secogorgost-5-en-9-one (7).
It is worth noting that the configurations of H-8 for compounds 3 and 4 were elucidated by comparing their 1H NMR data [12]. A large downfielding of the H-8 as well an upfielding of C-8 were identified to resonate from δH 2.69/δC 48.6 (compound 3) to δH 3.02/δC 43.8 (compound 4). Moreover, the 1H- and 13C-NMR spectroscopic features for positions 7 and 11 were also found to be different between these two compounds (3H 2.20 (H-7a, m) and δH 2.60 (H-7b, m)/δC 30.4 (C-7), 3.72 (H-11, 2H, t, J = 8.0 Hz)/δC 59.2 (C-11); 4H 1.98 (H-7a, m) and δH 2.40 (H-7b, m)/δC 33.0 (C-7), δH 3.83 (H-11a, 1H, m) and δH 3.68 (H-11b, 1H, m)/δC 59.3 (C-11)) (Supplementary Materials Figures S19–S22).

2.3. Anti-Inflammatory Assessment of Isolated 9,11-Secosterols

The anti-inflammatory properties of metabolites 17 were characterized by assessing the inhibition of superoxide anion generation and elastase release by human neutrophils in response to fMLP/CB (Table 3). Compounds 15 were shown to inhibit superoxide anion generation and elastase release, at concentrations ranging from 1.63 to 8.07 μM. The IC50 values of compounds 3 and 4 were lower than the other isolates. Secosteroid 7 presented activity at a concentration of 10 μM, indicating that the unique gorgosterol side chain nullified the anti-inflammatory activities.
N-Formyl peptide receptors (FPRs) are a family of G-protein coupled receptors involved in the switching on of leucocyte responses during inflammation. Human FPR1 is expressed primarily in neutrophils, monocytes, and macrophages. It also initiates immune reactions in response to several formyl peptide ligands derived from bacteria or mitochondria [13]. Researchers have previously proven that compounds acting as FPR1 antagonists exhibit anti-inflammatory activity in vitro and in vivo [14,15,16].
Flow cytometry was used to determine whether compounds 17 possess binding affinity to FPR1, the receptor-binding assay of N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein (fNLFNYK), an FPR1-specific fluorescent analog, on the surface of neutrophils. The results revealed that fMLF (10 μM) entirely inhibited the binding of fNLFNYK (2 nM), whereas only compound 2 presented a low affinity toward the FPR1 receptor at a concentration of 10 μM (Figure 4).

3. Experimental

3.1. General Procedures

The specific rotation of compounds was measured using a Jasco P-1010 digital polarimeter (Japan Spectroscopic Corporation, Tokyo, Japan). IR spectra were acquired using a Jasco FT/IR-4100 spectrometer (Japan Spectroscopic Corporation, Tokyo, Japan). NMR spectra were recorded on a Jeol Resonance ECZ400S NMR spectrometer (at 400 and 100 MHz for 1H and 13C NMR, respectively) using the residual CHCl3 signal (δH 7.26 ppm) as an international standard for 1H NMR and CDCl3C 77.1 ppm) for 13C NMR, respectively. ESIMS and HRESIMS were recorded using a mass spectrometer (7 Tesla SolariX FTMS system; Bruker, Bremen, Germany and Xevo G2-XS QToF; Waters Corporation, Wilmslow, UK). Silica gel (230–400 mesh, Merck, Darmstadt, Germany) was used for open-column chromatography. Reverse-phase MPLC (RP-MPLC) was performed using a system comprising a gradient controller Model 601 (FLOM, Tokyo, Japan) and two Dual Pumps Model 204 (FLOM, Tokyo, Japan). Reversed-phase HPLC (RP-HPLC) was performed using a system comprising of Nexera-i LC-2040C 3D (Shimadzu, Kyoto, Japan) with photodiode-array (PDA) detector and a Rheodyne 7725i injection port (Rheodyne LLC., Rohnert Park, CA, USA). Post-run analysis was performed using Labsolutions 5.90. A Biotage® SNAP Ultra C18 (12 g) flash cartridge (Biotage AB, Uppsala, Sweden) was used for RP-MPLC and a reverse phase column (COSMOSIL C18-AR-II, 10 × 250 mm, Nacalai Tesque, Inc., Kyoto, Japan) was used for RP-HPLC.

3.2. Coral Material

In November 2018, samples of the soft coral Sinularia leptoclados were obtained by hand using self-contained underwater breathing apparatus (SCUBA) off the coast of Pingtung, Taiwan. The samples were stored in a freezer at −20 °C until extraction. A specimen voucher was deposited with the Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Taiwan (specimen No.: CGUST-C004-2018-NOV).

3.3. Extraction and Isolation

Soft coral material (wet weight 1742 g, dry weight 488 g) was cut into small pieces prior to ethyl acetate (EtOAc) extraction at room temperature. The EtOAc layer (9.6 g; superoxide anion generation: IC50 3.97 μg/mL; elastase release: IC50 > 10 μg/mL) was separated on silica gel and eluted using n-hexane/EtOAc (stepwise, pure n-hexane−pure EtOAc−pure MeOH) to yield 22 fractions A−V. Fraction P (superoxide anion generation: IC50 3.57 μg/mL; elastase release: IC50 6.80 μg/mL) was further separated by RP-MPLC using a mixture of MeOH/ddH2O (v:v = 90:10 of volume ratio at a flow rate of 8.0 mL/min) to obtain compound 7 (82.5 mg) and nine subfractions, P1−P9. Subfraction P3 (superoxide anion generation: IC50 2.06 μg/mL; elastase release: IC50 1.45 μg/mL) was repurified by RP-HPLC using a mixture of acetonitrile/ddH2O (volume ratio of v:v = 90:10 at a flow rate of 2.0 mL/min) to derive 1 (2.6 mg), 2 (2.0 mg), 3 (3.5 mg), 4 (100.4 mg) and 5 (13.3 mg). Subfraction P4 was purified by RP-HPLC using a mixture of MeOH/ddH2O (volume ratio of v:v = 90:10 at a flow rate of 2.0 mL/min) to yield compound 6 (6.8 mg).
Sinleposterol A (1): colorless oil; [α ] D 22 −16.31 (c 0.095, CHCl3); IR (neat) νmax 3369, 2958, 1708 cm−1; 1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data (see Table 1); ESIMS: m/z 451 [M + Na]+; HRESIMS: m/z 451.31811 (calcd. for C28H44O3 + Na, 451.31827).
Sinleposterol B (2): colorless oil; [α ] D 24 −36 (c 0.1, CHCl3); IR (neat) νmax 3406, 2954, 1708 cm−1; 1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data (see Table 2); ESIMS: m/z 451 [M + Na]+; HRESIMS: m/z 451.3239 (calcd. for C28H44O3 + Na, 451.3188).

3.4. In Vitro Anti-Inflammatory Bioassay

3.4.1. Human Neutrophil Superoxide Anion Generation and Elastase Release

Blood samples were collected from healthy adult donors (20–32 years) via venipuncture in accordance with the standard protocol approved by the local institutional review board. Human neutrophils were isolated from peripheral blood through dextran sedimentation, centrifugation in a Ficoll–Hypaque gradient, and hypotonic lysis of red blood cells. In accordance with the above mentioned protocol, assays were performed to measure superoxide anion generation based on the superoxide dismutase-inhibitable reduction of ferricytochrome C. Note that methoxy-succinyl-alanyl-alanyl-prolyl-valine-p-nitroanilide (MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide) was used as the enzyme substrate for the detection of elastase release [17,18].

3.4.2. Receptor Binding Assay

Receptor binding assays were performed via FACScan analysis of fNLFNYK binding, a fluorescent analog of fMLF, as described in [16]. Neutrophils, differentiated THP-1, or FPR1-expressed HEK-293 were preincubated with test compounds at 4 °C for 5 min and then labelled with fNLFNYK for 30 min. Cells were immediately analyzed via flow cytometry.

3.4.3. Statistical Analysis

All experiments were conducted at least three times and the results are presented as the mean ± SEM. Statistical analysis was performed using the Student’s t-test, and a p value < 0.05 was considered statistically significant. Sigma Plot software (version 8.0, Systat Software, San Jose, CA, USA) was used for all statistical analysis [17].

4. Conclusions

Marine 9,11-secosteroid was first isolated from the gorgonian Pseudopterogorgia americana in 1972 [19]. Research since that time has revealed a variety of compounds in this group from a variety of invertebrates, including sponges, gorgonians, octocorals, ascidian, mollusk, and sea hare [7,20,21]. In recent years, 9,11-secosteroids have attracted considerable attention for their anti-inflammatory and antihepafibrosis properties [9,11,22,23,24,25]. This study strategically isolated two novel metabolites, sinleptosterols A and B, and five known compounds from the soft coral Sinularia leptoclados. The effectiveness of compounds 1–7 in inhibiting fMLP/CB-induced neutrophilic inflammation was also assessed. Compound 3 and 4 presented the most potent anti-inflammatory activities in terms of superoxide anion production and elastase emancipation. Cell free binding assays also demonstrated that the anti-inflammatory properties of these 9,11-secosteroids did not follow the pathway of conventional FPR1 antagonists.

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-3397/18/5/271/s1. HRESIMS, IR, 1D (1H NMR, 13C NMR, and DEPT spectra), and 2D (COSY, HSQC, HMBC, and NOESY) NMR spectra of new compounds 1 and 2. 1H NMR and 13C NMR spectra of compounds 3 and 4.

Author Contributions

Conceptualization, Y.-C.C., P.-J.S. and T.-L.H.; Formal analysis, Y.-C.C., P.-J.C. and Y.-H.W.; Funding acquisition, C.-L.L., H.-L.H. and T.-L.H.; Investigation, Y.-C.C.; Project administration, T.-L.H.; Resources, C.-L.L. and H.-L.H.; Supervision, H.-L.H. and T.-L.H.; Validation, P.-J.C. and Y.-H.W.; Writing—original draft, Y.-C.C.; Writing—review & editing, K.-H.L., S.K. and P.-J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by grants from the Chang Gung Medical Research Foundation (BMRP450, CMRPG6J0141~3, CMRPF1G0241~3, CMRPF1H0051~53; CMRPF1I0041~2 and CMRPF1J0051~3), the Chang Gung University of Science and Technology (ZRRPF3H0101, ZRRPF3H0111, ZRRPF3H0131, and ZRRPF3J0081), Ministry of Education (EMRPD1K0421, EMRPD1K0481, EMRPD1I0441 and EMRPD1I0501), and the Ministry of Science and Technology (MOST 106-2320-B-255-003-MY3, 108-2320-B-255-003-MY3, 107-2320-B-182A-004-MY2, MOST107-2320-B-255-003; MOST108-2320-B-255-002-MY3 and 106-2320-B-291-001-MY3), Taiwan.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Németh, T.; Sperandio, M.; Mócsai, A. Neutrophils as emerging therapeutic targets. Nat. Rev. Drug Discov. 2020, 19, 253–275. [Google Scholar] [CrossRef] [PubMed]
  2. Lin, S.C.; Shi, L.S.; Ye, Y.L. Advanced molecular knowledge of therapeutic drugs and natural products focusing on inflammatory cytokines in asthma. Cells 2019, 8, 685. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Sarma, N.S.; Krishna, M.S.; Pasha, S.G.; Rao, T.S.P.; Venkateswarlu, Y.; Parameswaran, P.S. Marine metabolites: The sterols of soft coral. Chem. Rev. 2009, 109, 2803–2828. [Google Scholar] [CrossRef] [PubMed]
  4. Su, J.H.; Tseng, Y.J.; Huang, H.H.; Ahmed, A.F.; Lu, C.K.; Wu, Y.C.; Sheu, J.H. 9,11-Secosterols from the soft corals Sinularia lochmodes and Sinularia leptoclados. J. Nat. Prod. 2006, 69, 850–852. [Google Scholar] [CrossRef]
  5. Cheng, S.Y.; Chen, H.P.; Wang, S.K.; Duh, C.Y. Three new 9,11-secosterols from the Formosan soft coral Sinularia leptoclados. Bull. Chem. Soc. Jpn. 2011, 84, 648–652. [Google Scholar] [CrossRef]
  6. Ngoc, N.T.; Hanh, T.T.H.; Thanh, N.V.; Thao, D.T.; Cuong, N.X.; Nam, N.H.; Thung, D.C.; Kiem, P.V.; Minh, C.V. Cytotoxic steroids from the Vietnamese soft coral Sinularia leptoclados. Chem. Pharm. Bull. 2017, 65, 593–597. [Google Scholar] [CrossRef] [Green Version]
  7. Sica, D.; Musumeci, D. Secosteroids of marine origin. Steroids 2004, 69, 743–756. [Google Scholar] [CrossRef]
  8. Tsai, C.R.; Huang, C.Y.; Chen, B.W.; Tsai, Y.Y.; Shih, S.P.; Hwang, T.L.; Dai, C.F.; Wang, S.Y.; Sheu, J.H. New bioactive steroids from the soft coral Klyxum flaccidum. RSC Adv. 2015, 5, 12546–12554. [Google Scholar] [CrossRef]
  9. Chang, Y.C.; Hwang, T.L.; Sheu, J.H.; Wu, Y.C.; Sung, P.J. New Anti-Inflammatory 9,11-Secosterols with a rare tricyclo[5,2,1,1]decane ring from a formosan gorgonian Pinnigorgia sp. Mar. Drugs 2016, 14, 218. [Google Scholar] [CrossRef] [Green Version]
  10. Chen, W.T.; Liu, H.L.; Yao, L.G.; Guo, Y.W. 9,11-Secosteroids and polyhydroxylated steroids from two South China Sea soft corals Sarcophyton trocheliophorum and Sinularia flexibilis. Steroids 2014, 92, 56–61. [Google Scholar] [CrossRef]
  11. Chang, Y.C.; Hwang, T.L.; Kuo, L.M.; Sung, P.J. Pinnisterols D–J, New 11-acetoxy-9,11-secosterols with a 1,4-quinone moiety from Formosan gorgonian coral Pinnigorgia sp. (Gorgoniidae). Mar. Drugs 2017, 15, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Bonini, C.; Cooper, C.B.; Kazlauskas, R.; Wells, R.J.; Djerassi, C. Minor and trace sterols in marine invertebrates. 41. Structure and stereochemistry of naturally occurring 9,11-seco sterols. J. Org. Chem. 1983, 48, 2108–2111. [Google Scholar] [CrossRef]
  13. Tsai, Y.F.; Yang, S.C.; Hwang, T.L. Formyl peptide receptor modulators: A patent review and potential applications for inflammatory diseases (2012–2015). Expert Opin. Ther. Pat. 2016, 26, 1139–1156. [Google Scholar] [CrossRef] [PubMed]
  14. Schepetkin, I.A.; Kirpotina, L.N.; Khlebnikov, A.I.; Cheng, N.; Ye, R.D.; Quinn, M.T. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones. Biochem. Pharmacol. 2014, 92, 627–641. [Google Scholar] [CrossRef] [Green Version]
  15. Kirpotina, L.N.; Schepetkin, I.A.; Khlebnikov, A.I.; Ruban, O.I.; Ge, Y.; Ye, R.D.; Kominsky, D.J.; Quinn, M.T. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists. Biochem. Pharmacol. 2017, 142, 120–132. [Google Scholar] [CrossRef]
  16. Yang, S.C.; Chang, S.H.; Hsieh, P.W.; Huang, Y.T.; Ho, C.M.; Tsai, Y.F.; Hwang, T.L. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1. Free Radic. Biol. Med. 2017, 106, 254–269. [Google Scholar] [CrossRef]
  17. Yang, S.C.; Chung, P.J.; Ho, C.M.; Kuo, C.Y.; Hung, M.F.; Huang, Y.T.; Chang, W.Y.; Chang, Y.W.; Chan, K.H.; Hwang, T.L. Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide–activated human neutrophils by blocking formyl peptide receptor 1. J. Immunol. 2013, 190, 6511. [Google Scholar] [CrossRef] [Green Version]
  18. Yu, H.P.; Hsieh, P.W.; Chang, Y.J.; Chung, P.J.; Kuo, L.M.; Hwang, T.L. 2-(2-Fluorobenzamido)- benzoate ethyl ester (EFB-1) inhibits superoxide production by human neutrophils and attenuates hemorrhagic shock-induced organ dysfunction in rats. Free Radic. Biol. Med. 2011, 50, 1737–1748. [Google Scholar] [CrossRef]
  19. Enwall, E.L.; van der Helm, D.; Hsu, I.N.; Pattabhiraman, T.; Schmitz, F.J.; Spraggins, R.L.; Weinheimer, A.J. Crystal structure and absolute configuration of two cyclopropane containing marine steroids. J. Chem. Soc. Chem. Commun. 1972, 215–216. [Google Scholar] [CrossRef]
  20. Van Wyk, A.W.W.; Gray, C.A.; Whibley, C.E.; Osoniyi, O.; Hendricks, D.T.; Caira, M.R.; Davies-Coleman, M.T. Bioactive metabolites from the South African marine mollusk Trimusculus costatus. J. Nat. Prod. 2008, 71, 420–425. [Google Scholar] [CrossRef]
  21. Kawamura, A.; Kita, M.; Kigoshi, H. Aplysiasecosterol A: A 9,11-Secosteroid with an unprecedented tricyclic γ-diketone structure from the sea hare Aplysia kurodai. Angew. Chem. Int. Ed. 2015, 54, 7073–7076. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Chang, Y.C.; Kuo, L.M.; Su, J.H.; Hwang, T.L.; Kuo, Y.H.; Lin, C.S.; Wu, Y.C.; Sheu, J.H.; Sung, P.J. Pinnigorgiols A–C, 9,11-secosterols with a rare ring arrangement from a gorgonian coral Pinnigorgia sp. Tetrahedron 2016, 72, 999–1004. [Google Scholar] [CrossRef]
  23. Chang, Y.C.; Kuo, L.M.; Hwang, T.L.; Yeh, J.; Wen, Z.H.; Fang, L.S.; Wu, Y.C.; Lin, C.S.; Sheu, J.H.; Sung, P.J. Pinnisterols A–C, New 9,11-secosterols from a gorgonian Pinnigorgia sp. Mar. Drugs 2016, 14, 12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Chang, Y.C.; Hwang, T.L.; Chao, C.H.; Sung, P.J. New marine sterols from a gorgonian Pinnigorgia sp. Molecules 2017, 22, 393. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Kuo, L.M.; Chen, P.J.; Sung, P.J.; Chang, Y.C.; Ho, C.T.; Wu, Y.H.; Hwang, T.L. The bioactive extract of Pinnigorgia sp. induces apoptosis of hepatic stellate cells via ROS-ERK/JNK-caspase-3 signaling. Mar. Drugs 2018, 16, 19. [Google Scholar] [CrossRef] [Green Version]
Figure 1. The structures of 9,11-secosteroids sinleptosterols A (1) and B (2), 8αH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (3), 8βH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (4), leptosterol A (5), (24S)-3β,11-dihydroxy-24-methyl-9,11-secocholest-5-en-9-one (6), and 3β,11-dihydroxy-9,11-secogorgost-5-en-9-one (7), and a picture of S. leptoclados.
Figure 1. The structures of 9,11-secosteroids sinleptosterols A (1) and B (2), 8αH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (3), 8βH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (4), leptosterol A (5), (24S)-3β,11-dihydroxy-24-methyl-9,11-secocholest-5-en-9-one (6), and 3β,11-dihydroxy-9,11-secogorgost-5-en-9-one (7), and a picture of S. leptoclados.
Marinedrugs 18 00271 g001
Figure 2. 1H-NMR spectra of fractions derived from the EtOAc extract of octocoral S. leptoclados extract as well as their corresponding inhibitory effects on superoxide anion generation (SIC50) and elastase release (EIC50) in N-Formylmethionyl-leucyl-phenylalanine (fMLF)/cytochalasin B (CB)-induced human neutrophils. * Both SIC50 and EIC50 are over 10 μg/mL.
Figure 2. 1H-NMR spectra of fractions derived from the EtOAc extract of octocoral S. leptoclados extract as well as their corresponding inhibitory effects on superoxide anion generation (SIC50) and elastase release (EIC50) in N-Formylmethionyl-leucyl-phenylalanine (fMLF)/cytochalasin B (CB)-induced human neutrophils. * Both SIC50 and EIC50 are over 10 μg/mL.
Marinedrugs 18 00271 g002
Figure 3. Selected NOESY correlations observed for 1.
Figure 3. Selected NOESY correlations observed for 1.
Marinedrugs 18 00271 g003
Figure 4. FPR1 receptor binding assay of compounds 17 in human neutrophils. Data are representative of three experiments. ** p < 0.01, *** p < 0.001 versus the control group.
Figure 4. FPR1 receptor binding assay of compounds 17 in human neutrophils. Data are representative of three experiments. ** p < 0.01, *** p < 0.001 versus the control group.
Marinedrugs 18 00271 g004
Table 1. 1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and COSY and HMBC for 1.
Table 1. 1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and COSY and HMBC for 1.
PositionδH (J in Hz)δC, TypeCOSYHMBC
1a/b1.50 m; 1.81 m31.0, CH2H2-2C-3
2a/b1.40 m; 1.93 m30.8, CH2H2-1, H-3n. o. a
33.51 m 71.4, CHH2-2, H2-4n. o.
4a/b2.23 m; 2.44 m40.6, CH2H-3C-3, C-5, C-6
5-140.4, C--
65.47 brd (5.6)121.5, CHH2-7C-4, C-7, C-8, C-10
7a/b1.98 m; 2.40 m 33.1, CH2H-6, H-8C-5, C-6
83.03 ddd (12.4, 12.4, 6.8)43.8, CHH2-7, H-14C-7, C-9, C-14
9-217.5, C--
10-48.4, C--
11a/b3.86 m; 3.74m59.4, CH2H2-12n. o.
121.33 m; 1.67 m40.2, CH2H2-11C-11, C-13
13-45.5, C--
142.61 m42.1, CHH-8, H2-15C-9
151.31 m; 1.58 m24.6, CH2H-14, H2-16C-14
161.31 m; 1.71 m24.8, CH2H2-15, H-17n. o.
171.78 m49.6, CHH2-16, H-20n. o.
180.69 s17.7, CH3-C-12, C-13, C-14, C-17
191.40 s22.8, CH3-C-1, C-5, C-9, C-10
202.25 m38.5, CHH-17, H3-21, H-22C-16
211.08 d (6.4)22.1, CH3H-20C-17, C-20
225.65 dd (16.0, 7.2)134.6, CHH-20, H-23C-20, C-21, C-24
235.93 d (16.0)130.2, CHH-22C-20, C-24, C-25, C-28
24-153.0, C -
252.54 m29.4, CHH3-26, H3-27C-24, C-28
261.06 d (6.8)22.4, CH3H-25C-24, C-25
271.07 d (6.8)21.5, CH3H-25C-24, C-25
284.83 d (6.8)109.8, CH2 C-24, C-25
a n. o. = not observed.
Table 2. 1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and COSY and HMBC for 2.
Table 2. 1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and COSY and HMBC for 2.
PositionδH (J in Hz)δC, TypeCOSYHMBC
1a/b1.53 m; 1.90 m30.8, CH2H2-2n. o. a
2a/b1.31 m; 1.93 m31.3, CH2H2-1, H-3n. o.
33.51 m 71.4, CHH2-2, H2-4n. o.
4a/b2.23 m; 2.44 m40.6, CH2H-3n. o.
5-140.4, C--
65.48 brd (5.6)121.5, CHH2-7C-4, C-7, C-8
7a/b2.02 m; 2.39 m33.0, CH2H-6, H-8n. o.
83.03 td (12.4, 6.8)43.6, CHH2-7, H-14C-7, C-9, C-14
9-217.5, C--
10-48.5, C--
11a/b3.69 m; 3.83m59.4, CH2H2-12n. o.
121.32 m; 1.68 m40.3, CH2H2-11n. o.
13-45.6, C--
142.61 m41.8, CHH-8, H2-15n. o.
151.30 m; 1.56 m24.4, CH2H-14, H2-16n. o.
161.30 m; 1.74 m25.0, CH2H2-15, H-17-
171.65 m49.2, CHH2-16-
180.67 s17.3, CH3-C-11, C-12, C-13, C-14, C-17
191.38 s22.9, CH3-C-1, C-5, C-9, C-10
201.41 m34.0, CHH3-21n. o.
211.01 d (6.8)19.4, CH3H-20C-17, C-20, C-22
221.17 m; 1.51 m34.7, CH2H-23n. o.
231.81 m; 2.39 m31.0, CH2H-22n. o.
24-148.5, C-
25-142.7, C-
264.59 d (1.2)112.5, CH2-C-25
271.90 s21.2, CH3-C-24, C-25, C-26
285.06 s112.0, CH2-C-23, C-24, C-25
a n. o. = not observed.
Table 3. Effects of compounds 17 on superoxide anion generation and elastase release in fMLF/CB-induced human neutrophils.
Table 3. Effects of compounds 17 on superoxide anion generation and elastase release in fMLF/CB-induced human neutrophils.
CompoundSuperoxide AnionsElastase Release
IC50 (μM) aInh %IC50 (μM)Inh %
17.07 ± 0.5264.76 ± 3.42 ***7.57 ± 0.4065.04 ± 2.76 ***
24.68 ± 0.5776.30 ± 5.09 ***4.29 ± 0.25105.09 ± 5.25 ***
31.97 ± 0.1290.47 ± 2.44 ***3.12 ± 0.07112.23 ±5.01 ***
42.96 ± 0.9191.11 ± 4.51 ***1.63 ± 0.1593.74 ± 1.23 ***
58.07 ± 0.5357.93 ± 2.30 ***4.73 ± 0.5786.32 ± 2.91 ***
64.09 ± 0.5060.51 ± 4.06 ***>1025.38 ± 6.68 **
7>1010.29 ± 5.42 ***>1018.87 ± 3.86 ***
Percentage of inhibition (Inh %) at 10 μM concentration. Results are presented as mean ± S.E.M. (n = 3 or 4). ** p < 0.01, *** p < 0.001 compared with the control (DMSO). a Concentration necessary for 50% inhibition (IC50).

Share and Cite

MDPI and ACS Style

Chang, Y.-C.; Lai, K.-H.; Kumar, S.; Chen, P.-J.; Wu, Y.-H.; Lai, C.-L.; Hsieh, H.-L.; Sung, P.-J.; Hwang, T.-L. 1H NMR-Based Isolation of Anti-Inflammatory 9,11-Secosteroids from the Octocoral Sinularia leptoclados. Mar. Drugs 2020, 18, 271. https://doi.org/10.3390/md18050271

AMA Style

Chang Y-C, Lai K-H, Kumar S, Chen P-J, Wu Y-H, Lai C-L, Hsieh H-L, Sung P-J, Hwang T-L. 1H NMR-Based Isolation of Anti-Inflammatory 9,11-Secosteroids from the Octocoral Sinularia leptoclados. Marine Drugs. 2020; 18(5):271. https://doi.org/10.3390/md18050271

Chicago/Turabian Style

Chang, Yu-Chia, Kuei-Hung Lai, Sunil Kumar, Po-Jen Chen, Yi-Hsuan Wu, Ching-Long Lai, Hsi-Lung Hsieh, Ping-Jyun Sung, and Tsong-Long Hwang. 2020. "1H NMR-Based Isolation of Anti-Inflammatory 9,11-Secosteroids from the Octocoral Sinularia leptoclados" Marine Drugs 18, no. 5: 271. https://doi.org/10.3390/md18050271

APA Style

Chang, Y. -C., Lai, K. -H., Kumar, S., Chen, P. -J., Wu, Y. -H., Lai, C. -L., Hsieh, H. -L., Sung, P. -J., & Hwang, T. -L. (2020). 1H NMR-Based Isolation of Anti-Inflammatory 9,11-Secosteroids from the Octocoral Sinularia leptoclados. Marine Drugs, 18(5), 271. https://doi.org/10.3390/md18050271

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop